x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Xtalks Life Science Podcast

This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.

science life sciences

All Episodes

32:53

The Biology of Aging: Innovations in Cellular...

Xtalks Life Science Podcast ·

2025/12/03

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Sharon Rosenzweig-Lipson, PhD, Chief Scientific Officer (CSO) at Life Biosciences, a company advancing cellular rejuvenation gene therapies to treat age-related diseases.The company is targeting eye diseases like glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION). Dr. Rosenzweig-Lipson has held leadership positions in both big pharma and small

en-us

38:33

The Evolving Landscape of Respiratory and Immunology...

Xtalks Life Science Podcast ·

2025/11/26

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Andrew Menzies-Gow, MBBS, PhD, Vice President Respiratory & Immunology, Global Biopharmaceuticals Medical, AstraZeneca, about innovations in respiratory and immunology drug development.Dr. Menzies-Gow is an expert in respiratory biologics and severe asthma research with a prolific career in respiratory medicine, combining his background as a practicing clinician

en-us

30:35

Restoring Lost Synapses in ALS, Fragile X and More...

Xtalks Life Science Podcast ·

2025/11/19

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Peter Vanderklish, PhD, chief scientific officer at Spinogenix, a company developing therapeutics aimed at restoring synaptic connections for conditions such as ALS, Alzheimer’s disease, schizophrenia and Fragile X syndrome.Dr. Vanderklish’s decades of research, from his graduate work at UC Irvine to his roles at The Scripps Research Institute and UC Irvine, have

en-us

39:54

Targeting Protein Misfolding and Innovations in...

Xtalks Life Science Podcast ·

2025/11/11

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Pol Boudes, MD, Chief Medical Officer at Rectify Pharma.Rectify Pharma is a biotechnology company pioneering a positive functional modulators (PFM) platform to address the root causes of genetic and protein folding diseases in the liver, cardio-renal-metabolic and neurodegenerative spaces. The company’s lead program is in hepatobiliary diseases. Dr. Boudes has more

en-us

35:55

Advancing Rare Disease Treatment and Care with...

Xtalks Life Science Podcast ·

2025/11/05

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Mike Denne, PharmD, Vice President of US Medical Affairs for Rare Disease and Plasma Derived Therapies at Takeda, to discuss the company’s approach to advancing patient care in the area of rare diseases through medical innovation and collaboration.With over 15 years of leadership experience in medical affairs, Dr. Denne shares his insights on building effective and

en-us

31:57

Advancing Gene Therapies for Diabetes and...

Xtalks Life Science Podcast ·

2025/10/29

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, welcomes Mike Exton, PhD, CEO of Lexicon Pharmaceuticals, for a conversation about leveraging gene science to develop innovative medicines for serious chronic conditions.Dr. Exton discusses Lexicon’s growing pipeline, which includes promising therapies for diabetic peripheral neuropathic pain, hypertrophic cardiomyopathy and other cardiometabolic diseases, areas where unmet

en-us

42:07

At the Heart of Gene Therapy: Lexeo’s R. Nolan...

Xtalks Life Science Podcast ·

2025/10/22

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with R. Nolan Townsend, MBA, CEO of Lexeo Therapeutics, a company developing gene therapies for cardiovascular diseases as well as CNS disorders including Alzheimer’s disease.Lexeo recently announced a partnership to advance cardiac RNA therapeutics as well as $80 million in equity financing. Mr. Townsend has been CEO of Lexeo Therapeutics since 2020. He previously held

en-us

38:09

Teaching the Pancreas to Heal Itself: Dr. Juan...

Xtalks Life Science Podcast ·

2025/10/15

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with Juan Domínguez-Bendala, PhD, Director of Stem Cell and Pancreatic Regeneration Programs, Diabetes Research Institute (DRI) at the University of Miami, to discuss his research team’s new research published in Nature Communications that could redefine diabetes treatment.Dr. Domínguez-Bendala team’s study reveals how THR-123, a small peptide, can trigger the

en-us

35:17

From Lab to Launch: Spinning out Biotech Innovation...

Xtalks Life Science Podcast ·

2025/10/08

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, sits down with Paul Wotton, PhD, CEO of RBL LLC, a venture studio partially owned by Rice University.RBL’s mission is to transform groundbreaking research from the Rice Biotech LaunchPad into successful biotech startups. The company provides end-to-end support for early-stage ventures, from financial and business development services to clinical trial design, talent

en-us

31:32

Exploring the Future of Cannabinoid & Psychedelic...

Xtalks Life Science Podcast ·

2025/09/30

In this episode of the Xtalks Life Science Podcast, Senior Life Science Journalist Ayesha Rashid speaks with Joel Latham, CEO, president and director of Incannex Healthcare, to discuss how the company is advancing cannabinoid and psychedelic therapies for chronic conditions like sleep apnea, rheumatoid arthritis and anxiety disorders.Joel has more than 20 years of senior management and operations experience in both public and private sectors. Under Joel’s leadership, Incannex has advanced and

en-us

33:38

Driving Innovation in Oncology: Insights from Jeff...

Xtalks Life Science Podcast ·

2025/09/24

In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid, speaks with Jeff Glazier, CEO and founding member of General Oncology. General Oncology is focused on advancing innovative therapies that address some of the greatest unmet needs in oncology.At General Oncology, Jeff has overseen everything from corporate strategy and clinical trial site selection to IP protection and IT infrastructure. He stepped into the role of CEO in August 2024, bringing a vision for translating

en-us

55:49

The Next Generation of Cell Therapy with Cartherics’...

Xtalks Life Science Podcast ·

2025/09/17

In this episode of the Xtalks Life Science Podcast, we dive into the cutting edge of cell therapy innovation with Ian Nisbet, PhD, chief operating officer (COO) and co-founder of Cartherics, an Australian biotech company developing next-generation cell therapies for difficult-to-treat diseases like cancer and endometriosis.Dr. Nisbet also acts as a director or advisor to several Australian and US biotechnology companies. With more than 35 years of leadership in biotech and experience in bringing

en-us

35:54

Why MASH Matters: The Next Steps in Liver Disease...

Xtalks Life Science Podcast ·

2025/09/10

In this episode of the Xtalks Life Science Podcast, Editor-in-Chief Vera Kovacevic speaks with Rohan Palekar, CEO of 89bio, about one of the fastest-growing public health challenges: metabolic dysfunction-associated steatohepatitis (MASH), also known as fatty liver disease.MASH is projected to affect more than 27 million Americans by 2030, yet it remains a largely “silent” epidemic. Palekar discusses what sets MASH apart from other liver diseases, the urgent need for therapies that can rapidly

en-us

35:55

Bridging Aesthetics and Therapeutics in Dermatology...

Xtalks Life Science Podcast ·

2025/09/03

In this episode of the Xtalks Life Science Podcast, Senior Life Science Journalist Ayesha Rashid connects with Bill Andriopoulos, PhD, Vice President of Medical Affairs at Galderma US, to discuss the future of patient-centered dermatology across both medical and aesthetic care. Galderma is focused on advancing science-based innovations in the dermatology space. Together, they discuss Galderma’s approach to responsible innovation, improving access and representation in research, and what it takes to

en-us

51:16

The Neuroscience of Weight Regulation with Courage...

Xtalks Life Science Podcast ·

2025/08/27

In this episode of the Xtalks Life Science Podcast, Senior Life Science Journalist Ayesha Rashid speaks with Dr. Roger Cone, PhD, founder of Courage Therapeutics, professor at the University of Michigan, a member of the National Academy of Sciences and a leading authority on the neuroscience of weight regulation.Dr. Cone shares insights from over 30 years of groundbreaking research on the brain’s melanocortin system, discoveries that have revolutionized our understanding of obesity and restrictive

en-us

37:53

Exploring Immunomodulation Without Immunosuppression...

Xtalks Life Science Podcast ·

2025/08/19

In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid speaks with Rob Armstrong, PhD, CEO of Artax Biopharma, a company pioneering a novel class of oral small molecule drugs known as Nck modulators to treat autoimmune diseases. Unlike traditional therapies that suppress the immune system, Artax’s approach aims to restore immune balance by modulating T cell receptor signaling.Dr. Armstrong shares insights into the company’s recent clinical progress, including positive Phase IIa

en-us

37:11

Advancing Neurotherapeutics for Fragile X and Beyond...

Xtalks Life Science Podcast ·

2025/08/13

In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Craig Erickson, MD, chief medical officer at Spinogenix and a leading expert in translational neurodevelopmental research.Dr. Erickson shares insights into Spinogenix’s work on restoring synapses to reverse cognitive and motor decline in conditions like Fragile X Syndrome, ALS, Alzheimer’s disease and schizophrenia. Dr. Erickson is a Professor of Psychiatry at the University of Cincinnati College of Medicine-Affiliated and the

en-us

44:15

Driving Neuro Innovation with Neurizon Therapeutics...

Xtalks Life Science Podcast ·

2025/08/06

In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Michael Thurn, PhD, Managing Director & CEO, Neurizon Therapeutics, a company focused on advancing treatments for neurodegenerative diseases, including ALS, with expansion efforts in Alzheimer’s, Parkinson’s, Huntington’s and others. With over 25 years of experience in biotech innovation, entrepreneurship and leadership and broad experience in drug discovery, development, regulation and commercialization, Dr. Thurn shares his

en-us

38:49

Restoring Synapses to Fight ALS, Alzheimer’s and More...

Xtalks Life Science Podcast ·

2025/07/30

In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Stella Sarraf, PhD, founder, CEO and director of Spinogenix, a company pioneering neurodegenerative therapeutics designed to restore synapses with the potential to reverse cognitive and motor decline in conditions such as ALS, Alzheimer’s disease, schizophrenia and other neurological disorders. Dr. Sarraf shares the scientific inspiration behind Spinogenix’s novel approach and how the company is pushing the boundaries of what’s

en-us

38:14

Championing the Patient Voice with Ardelyx’s Chief...

Xtalks Life Science Podcast ·

2025/07/23

In this episode of the Xtalks Life Science Podcast, Ayesha Rashid speaks with Laura Williams, MD, MPH, chief patient officer at Ardelyx, a company developing and commercializing first-in-class medicines for diseases like chronic kidney disease (CKD) and irritable bowel syndrome (IBS).Dr. Williams brings nearly 30 years of experience in clinical development, drug strategy and patient advocacy. With leadership roles across big pharma and biotech — including Abbott, Myovant and AMAG Pharmaceuticals —

en-us

234 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter